Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
Items 101–200 of 816
Butler, T. A. J., Paúl, J., Chan, E., Smith, R., & Tolosa, J. M. (2019) · BioMed Research International · doi:10.1155/2019/5214821 · Cited by 94
Antibody Validation by Western Blotting
Signore, M., Manganelli, V., & Hodge, A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6990-6_4 · Cited by 84
A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
Gupta, A. R., Anand, A., Jain, N., Goswami, S., Anantharaj, A., Patil, S., Singh, R., Kumar, A., Shrivastava, T., Bhatnagar, S., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.06.014 · Cited by 83
“Further, even if we are lucky, getting a good antibody may take several months.(14) Alternatively, detection of immunoglobulin M (IgM) and IgG in patient sera using recombinant viral antigens can be a reasonable and pragmatic approach, but it suffers from poor sensitivity as seroconversion takes several days to weeks…”
Filograna, R., Civiero, L., Ferrari, V., Codolo, G., Greggio, E., Bubacco, L., Beltramini, M., & Bisaglia, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136769 · Cited by 82
“The next step would have been a Western blot analysis to detect the translation products of the analyzed genes, but the scanty reliability of some of the available antibodies hindered trustworthy quantification [32, 33].”
BackgroundSheng, Y., Wang, K., Lu, Q., Ji, P., Liu, B., Zhu, J., Liu, Q., Sun, Y., Zhang, J., Zhou, E., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0468-0 · Cited by 83
Electrochemical aptasensors for cancer diagnosis in biological fluids – A review
Díaz‐Fernández, A., Lorenzo-Gómez, R., Miranda‐Castro, R., de-los-Santos-Álvarez, N., & Lobo-Castañón, M. J. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.04.022 · Cited by 81
A subcellular map of the human kinome
Zhang, H., Cao, X., Tang, M., Zhong, G., Si, Y., Li, H., Zhu, F., Liao, Q., Li, L., Zhao, J., et al. (2021) · eLife · doi:10.7554/elife.64943 · Cited by 83
“However, reliability was limited by antibody specificity in such one antibody one protein approaches (Baker, 2015).”
BackgroundDiffusing protein binders to intrinsically disordered proteins
Liu, C., Wu, K., Choi, H., Han, H. L., Zhang, X., Watson, J. L., Ahn, G., Zhang, J. Z., Shijo, S., Good, L. L., et al. (2025) · Nature · doi:10.1038/s41586-025-09248-9 · Cited by 79
de Waal, G. M., Engelbrecht, L., Davis, T., de Villiers, W. J. S., Kell, D. B., & Pretorius, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-35009-y · Cited by 77
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Hunter, S., & Brayne, C. (2017) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-017-0066-3 · Cited by 77
“Concerns regarding the interpretation and reliability of antibodies relating to reproducibility of science in general have been previously highlighted [27].”
BackgroundGuidelines for authors and reviewers on antibody use in physiology studies
Brooks, H. L., & Lindsey, M. L. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00512.2017 · Cited by 84
“It is estimated that up to 50% of studies are not reproducible as published; of these, ~35% of the issue can be attributed to biological reagents, including antibody use (1, 5, 12, 33, 46).”
BackgroundNanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
Tiambeng, T. N., Roberts, D. S., Brown, K. A., Zhu, Y., Chen, B., Wu, Z., Mitchell, S. D., Guardado-Alvarez, T. M., Jin, S., & Ge, Y. (2020) · Nature Communications · doi:10.1038/s41467-020-17643-1 · Cited by 76
Molecular tools for coral reef restoration: Beyond biomarker discovery
Parkinson, J. E., Baker, A. C., Baums, I. B., Davies, S. W., Grottoli, A. G., Kitchen, S. A., LaJeunesse, T. C., Matz, M. V., Miller, M. W., Shantz, A. A., et al. (2019) · Conservation Letters · doi:10.1111/conl.12687 · Cited by 82
“However, antibodies needed for immunohistochemistry-based approaches are difficult to standardize across production batches (Baker, 2015) and proteomic methods have yet to catch up to their genomic and transcriptomic counterparts in terms of throughput and repeatability, both for sample preparation…”
Harris, B. N. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.113355 · Cited by 83
The empirical replicability of task-based fMRI as a function of sample size
Bossier, H., Roels, S. P., Seurinck, R., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Quinlan, E. B., Desrivières, S., Flor, H., Grigis, A., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116601 · Cited by 86
“The topic of replicating scientific results has been addressed in several fields such as psychology (Open Science Collaboration, 2015), biomedical sciences (Baker, 2015) or neurosciences (Poldrack et al.”
Bandrowski, A. E., & Martone, M. E. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.030 · Cited by 75
“…need to be included in the material data sheet and what sorts of experiments need to be done to verify that an antibody is working within a researcher’s lab (IWGAV and GBSI; Baker 2015b; Alm et al., 2016), each antibody should be registered with the Antibody Registry and obtain a stable identifier.”
BackgroundThe 27th annual Nucleic Acids Research database issue and molecular biology database collection
Rigden, D. J., & Fernández, X. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1161 · Cited by 75
Allosteric Inhibition of a Semaphorin 4D Receptor Plexin B1 by a High-Affinity Macrocyclic Peptide
Matsunaga, Y., Bashiruddin, N. K., Kitago, Y., Takagi, J., & Suga, H. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.09.015 · Cited by 76
The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
Wang, S., Qiu, Y., & Bai, B. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00614 · Cited by 75
Fulcher, J. M., Markillie, L. M., Mitchell, H. D., Williams, S., Engbrecht, K. M., Degnan, D. J., Bramer, L., Moore, R., Chrisler, W., Cantlon-Bruce, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54099-z · Cited by 90
“These measurements also require intermediate antibodies to recognize epitopes, which can be limited by availability and speci fi city 15,16 .”
Boehm, U., Nelson, G., Brown, C. M., Bagley, S., Bajcsy, P., Bischof, J., Dauphin, A., Dobbie, I. M., Eriksson, J., Faklaris, O., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01162-y · Cited by 89
On-site airborne pathogen detection for infection risk mitigation
Qiu, G., Zhang, X., deMello, A. J., Yao, M., Cao, J., & Wang, J. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00417a · Cited by 77
The ABCD database: a repository for chemically defined antibodies
de Lima, W. C., Gasteiger, E., Marcatili, P., Duek, P. D., Bairoch, A., & Cosson, P. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz714 · Cited by 91
Wiśniewski, J. R., & Mann, M. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00403 · Cited by 79
Reporter–nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents
Yamagata, M., & Sanes, J. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722491115 · Cited by 72
“Polyclonal antibodies from immunized animals are often poorly defined, available in limited amounts, and variable from bleed to bleed (4, 5).”
BackgroundPeng, W., Pronker, M. F., & Snijder, J. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00169 · Cited by 71
Refining animal research: The Animal Study Registry
Bert, B., Heinl, C., Chmielewska, J., Schwarz, F., Grune, B., Hensel, A., Greiner, M., & Schönfelder, G. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000463 · Cited by 67
“Misidentification or contamination of reagents, biologicals, and cell lines used have been named as further causes [10].”
BackgroundXing, R., Wen, Y., He, H., Guo, Z., & Liu, Z. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.11.033 · Cited by 65
Vollero, A., Sardanelli, D., & Siano, A. (2021) · Journal of Consumer Behaviour · doi:10.1002/cb.1969 · Cited by 71
The challenges with the validation of research antibodies
Voskuil, J. L. A. (2017) · F1000Research · doi:10.12688/f1000research.10851.1 · Cited by 66
Exploring single cells in space and time during tissue development, homeostasis and regeneration
Mayr, U., Serra, D., & Liberali, P. (2019) · Development · doi:10.1242/dev.176727 · Cited by 63
“Protein detection relies on high-affinity reagents (most often antibodies), which, compared with nucleotide detection of RNAs, impairs flexibility of probe design (Baker, 2015).”
BackgroundA toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors
Venkataraman, A., Yang, K., Irizarry, J., Mackiewicz, M., Mita, P., Kuang, Z., Xue, L., Ghosh, D., Liu, S., Ramos, P., et al. (2018) · Nature Methods · doi:10.1038/nmeth.4632 · Cited by 62
Li, P., Pang, J., Xu, S., He, H., Ma, Y., & Liu, Z. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202113528 · Cited by 64
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies
Waters, A. M., Ozkan-Dagliyan, I., Vaseva, A. V., Fer, N., Strathern, L. A., Hobbs, G. A., Tessier-Cloutier, B., Gillette, W. K., Bagni, R., Whiteley, G. R., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aao3332 · Cited by 61
Microchip-based single-cell functional proteomics for biomedical applications
Lu, Y., Liu, Y., Wei, W., & Shi, Q. (2017) · Lab on a Chip · doi:10.1039/c7lc00037e · Cited by 62
Aptamer-functionalized capacitive biosensors
Weaver, S., Mohammadi, M. H., & Nakatsuka, N. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.115014 · Cited by 60
Marsault, É., Llorens‐Cortés, C., Iturrioz, X., Chun, H. J., Lesur, O., Oudit, G. Y., & Auger‐Messier, M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14123 · Cited by 69
Roncador, G., Engel, P., Maestre, L., Anderson, A. P., Cordell, J., Cragg, M. S., Šerbec, V. Č., Jones, M., Lisnić, V. J., Kremer, L., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1100787 · Cited by 65
Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis
Petruccioli, E., Petrone, L., Vanini, V., Cuzzi, G., Navarra, A., Gualano, G., Palmieri, F., Girardi, E., & Goletti, D. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.07.009 · Cited by 64
An in silico method to assess antibody fragment polyreactivity
Harvey, E. P., Shin, J.-E., Skiba, M. A., Nemeth, G. R., Hurley, J. D., Wellner, A., Shaw, A. Y., Miranda, V. G., Min, J. K., Liu, C. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35276-4 · Cited by 56
Maximising the translation potential of electrochemical biosensors
Docherty, N., Macdonald, D., Gordon, A., Dobrea, A., Mani, V., Fu, Y., Pang, S., Jimenez, M., & Corrigan, D. K. (2025) · Chemical Communications · doi:10.1039/d5cc02322j · Cited by 64
Proteomic Analysis of Histone Variants and Their PTMs: Strategies and Pitfalls
Kennani, S. E., Crespo, M., Govin, J., & Pflieger, D. (2018) · Proteomes · doi:10.3390/proteomes6030029 · Cited by 66
“As a result, histone antibodies are not always specific for their targets and often generate cross-reactivity [18].”
BackgroundShuken, S. R., & McNerney, M. W. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03719 · Cited by 65
Getting rigorous with scientific rigor
Hofseth, L. J. (2018) · Carcinogenesis · doi:10.1093/carcin/bgx085 · Cited by 56
“Recent initiatives aimed at enduring rigor spawning from a perceived ‘reproducibility crisis’ (16) will help steer the ship in the right direction.”
BackgroundTen Basic Rules of Antibody Validation
Weller, M. G. (2018) · Analytical Chemistry Insights · doi:10.1177/1177390118757462 · Cited by 62
YCharOS open antibody characterisation data: Lessons learned and progress made
Biddle, M., & Virk, H. S. (2023) · F1000Research · doi:10.12688/f1000research.141719.1 · Cited by 56
The Antibody Society’s antibody validation webinar series
Voskuil, J. L. A., Bandrowski, A., Begley, C. G., Bradbury, A. R. M., Chalmers, A. D., Gomes, A. V., Hardcastle, T., Lund-Johansen, F., Plückthun, A., Roncador, G., et al. (2020) · mAbs · doi:10.1080/19420862.2020.1794421 · Cited by 54
Xu, W., Gu, J., Ren, Q., Shi, Y., Xia, Q., Wang, J., Wang, S., Wang, Y., & Wang, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4245-x · Cited by 54
“irreproducibility of biomedical research that mainly is caused by correctness or specificity of primary antibodies involved and employed [20, 21], the antibody against NFATC1 in our”
BackgroundEvaluation of milk cathelicidin for detection of bovine mastitis
Addis, M. F., Tedde, V., Puggioni, G., Pisanu, S., Casula, A., Locatelli, C., Rota, N., Bronzo, V., Moroni, P., & Uzzau, S. (2016) · Journal of Dairy Science · doi:10.3168/jds.2016-11407 · Cited by 56
“Instead of by measuring enzyme activity, mastitis-related biomarkers can be detected by developing dedicated immunoassay strategies, provided that reliable antibodies are available to warrant assay robustness and reproducibility (Baker, 2015).”
BackgroundSurface Plasmon Resonance: A Boon for Viral Diagnostics
Singh, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.12245-9 · Cited by 62
“Therefore, it is not possible to compare the sensitivity and specificity of these sensors (Baker, 2015).”
BackgroundRelevance of Antibody Validation for Flow Cytometry
Kalina, T., Lundsten, K., & Engel, P. (2019) · Cytometry Part A · doi:10.1002/cyto.a.23895 · Cited by 60
“Antibodies are believed to be, in part, responsible for inconsistent experimental results and the publication of inaccurate data in the scientific literature (12,13).”
ResultAyoubi, R., Ryan, J., Biddle, M. S., Alshafie, W., Fotouhi, M., Bolivar, S. G., Ruiz Moleon, V., Eckmann, P., Worrall, D., McDowell, I., et al. (2023) · eLife · doi:10.7554/elife.91645.2 · Cited by 53
Wolters, J. C., Čiapaitė, J., van Eunen, K., Niezen‐Koning, K. E., Matton, A. P. M., Porte, R. J., Horvatovich, P. L., Bakker, B. M., Bischoff, R., & Permentier, H. P. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00419 · Cited by 53
Hong, S.-L., Wan, Y.-T., Tang, M., Pang, D., & Zhang, Z. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00684 · Cited by 52
Nanobodies reveal an extra-synaptic population of SNAP-25 and Syntaxin 1A in hippocampal neurons
Maidorn, M., Olichon, A., Rizzoli, S. O., & Opazo, F. (2018) · mAbs · doi:10.1080/19420862.2018.1551675 · Cited by 55
Nonlytic Recombinant Phage Tail Fiber Protein for Specific Recognition of Pseudomonas aeruginosa
He, Y. Q., Shi, Y., Liu, M., Wang, Y., Wang, L., Lu, S., & Fu, Z. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04160 · Cited by 52
Antibodies and methods for immunohistochemistry of extracellular matrix proteins
Rickelt, S., & Hynes, R. O. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.011 · Cited by 53
“Antibody validation recommendations Although the quality of diagnostic and research antibodies remains a problem [27, 32-34], several attempts to improve antibody validation have been made and very useful”
BackgroundHarnessing QbD, Programming Languages, and Automation for Reproducible Biology
Sadowski, M. I., Grant, C., & Fell, T. S. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.11.006 · Cited by 60
Tools and limitations to study the molecular composition of synapses by fluorescence microscopy
Maidorn, M., Rizzoli, S. O., & Opazo, F. (2016) · Biochemical Journal · doi:10.1042/bcj20160366 · Cited by 54
Zhou, J. W., Zheng, S., Liu, T., Liu, Q., Chen, Y., Tan, D., Ma, R., & Lu, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26918 · Cited by 54
Mapping the discursive dimensions of the reproducibility crisis: A mixed methods analysis
Nelson, N. C., Ichikawa, K., Chung, J., & Malik, M. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254090 · Cited by 54
“For example, the title of Nature News feature “Reproducibility crisis: blame it on the antibodies,” suggests a singular explanation for reproducibility problems, which is reinforced in the body of the article with a quote asserting that “poorly characterized antibodies probably contribute to the problem more than any…”
BackgroundAptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
Haßel, S. K., & Mayer, G. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00400-6 · Cited by 49
Ekhtiari, H., Ghobadi‐Azbari, P., Thielscher, A., Antal, A., Li, L. M., Shereen, A. D., Cabral‐Calderín, Y., Keeser, D., Bergmann, T. O., Jamil, A., et al. (2022) · Nature Protocols · doi:10.1038/s41596-021-00664-5 · Cited by 55
Subcellular Transcriptomics and Proteomics: A Comparative Methods Review
Christopher, J. A., Geladaki, A., Dawson, C. S., Vennard, O. L., & Lilley, K. S. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100186 · Cited by 51
“These drawbacks have caused major reproducibility crises amongst the scientific community (35).”
BackgroundGuo, K. X., Zheng, S., Xu, Y., Xu, X., Chen, B., & Wen, Y. H. (2016) · Tumor Biology · doi:10.1007/s13277-016-5158-z · Cited by 52
Georgieva, A. Y., Gordon, E. R. L., & Weirauch, C. (2017) · PeerJ · doi:10.7717/peerj.3826 · Cited by 50
Gray, E. R., Brookes, J. C., Caillat, C., Turbé, V., Webb, B. L. J., Granger, L. A., Miller, B. S., McCoy, L. E., Khattabi, M. E., Verrips, C. T., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00189 · Cited by 48
Li, D., Morisseau, C. H. P., McReynolds, C. B., Duflot, T., Bellien, J., Nagra, R. M., Taha, A. Y., & Hammock, B. D. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01115 · Cited by 50
Fodor, I., Urban, P. P., Scott, A. P., & Pirger, Z. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110949 · Cited by 52
“…LH and/or FSH (Nuurai et al., 2020; Omran, 2012) and immunostaining has been deemed to be a highly unreliable technique for identifying proteins (Baker, 2015a,b) and over 50% of worldwide studies have in fact been described by Bradbury, Plückthun and 110 co-signatories (Bradbury and Plückthun,…”
MethodWu, X., Deng, L., Tang, D., Ying, G., Yao, X., Liu, F., & Gui, L. (2015) · Tumor Biology · doi:10.1007/s13277-015-4506-8 · Cited by 47
“First of all, both the clinical sample sizes of HCC tissues and cell lines were limited and may therefore lead to potentially biased and insufficient conclusions [21, 22]; secondly, given that the specificity of primary antibody that should have been evaluated and tested prior to being used [23, 24] otherwise may cont…”
MethodHu, X., Rajesh, M., Zhang, J., Zhou, S., Wang, S., Sun, J., Tan, Y., Zheng, Y., & Cai, L. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.01.020 · Cited by 47
Antibody specificity and promiscuity
Jain, D., & Salunke, D. M. (2019) · Biochemical Journal · doi:10.1042/bcj20180670 · Cited by 49
Aptamers: an emerging class of bioaffinity ligands in bioactive peptide applications
Acquah, C., Agyei, D., Obeng, E. M., Pan, S., Tan, K. X., & Danquah, M. K. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1564234 · Cited by 47
“…debates in recent literature regarding the justification of spending too much resources, both temporal and monetary, and whether the ‘once-hailed blessings to grace the drug therapy domain’ seriously deserve the hype and live up to the expectations (Baker 2015; Bradbury and Pl€uckthun 2015a).”
BackgroundInfluentialA Framework for Improving the Quality of Research in the Biological Sciences
Casadevall, A., Ellis, L. M., Davies, E. W., McFall-Ngai, M., & Fang, F. C. (2016) · mBio · doi:10.1128/mbio.01256-16 · Cited by 46
“For example, in the experimental preclinical medical sciences there is concern that some of the lack of reproducibility is caused by reagent problems such as contaminated cell lines (26), antibodies with poor specificity (27), and poor standardization of protein reagents (28).”
BackgroundAnalytical Protein Microarrays: Advancements Towards Clinical Applications
Sauer, U. (2017) · Sensors · doi:10.3390/s17020256 · Cited by 46
Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications
Hays, E., Duan, W., & Shigdar, S. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122576 · Cited by 49
“Antibody generation occurs in vivo, in both a time consuming and costly process, with incidences of great batch-to-batch variability [21].”
BackgroundBlunsom, N. J., Gomez-Espinosa, E., Ashlin, T. G., & Cockcroft, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.12.005 · Cited by 48
The antibody horror show: an introductory guide for the perplexed
Goodman, S. L. (2018) · New Biotechnology · doi:10.1016/j.nbt.2018.01.006 · Cited by 48
Gu, J., Wang, G., Liu, H., & Xiong, C. (2018) · Cell Proliferation · doi:10.1111/cpr.12455 · Cited by 46
ADIPOR1 is essential for vision and its RPE expression is lost in the Mfrprd6 mouse
Sluch, V. M., Banks, A., Li, H., Crowley, M. A., Davis, V., Xiang, C., Yang, J., Demirs, J. T., Vrouvlianis, J., Leehy, B. D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32579-9 · Cited by 51
Molecular imprinting of glycoproteins: From preparation to cancer theranostics
Ali, M. M., Zhu, S., Amin, F. R., Hussain, D., Du, Z., & Hu, L. (2022) · Theranostics · doi:10.7150/thno.69189 · Cited by 49
“Often, antibodies' stability and reproducibility are troublesome [14, 15].”
BackgroundEmerging albumin hydrogels as personalized biomaterials
Kong, F., Mehwish, N., & Lee, B. H. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.058 · Cited by 47
Sánchez‐Salcedo, R., Miranda‐Castro, R., de-los-Santos-Álvarez, N., Lobo-Castañón, M. J., & Corrigan, D. K. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04973-4 · Cited by 45
“However, the variability between different batches, the difficult process and high costs of obtaining monoclonal Abs [27], and their large relative molecular weight serving as a limiting factor of sensitivity in impedance assays make it necessary to explore alternative bioreceptors.”
BackgroundImmunocapture strategies in translational proteomics
Fredolini, C., Byström, S., Pin, E., Edfors, F., Tamburro, D., Iglesias, M. J., Månberg, A., Hong, M., Uhlén, M., Nilsson, P., et al. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1111141 · Cited by 53
Evaluation of milk cathelicidin for detection of dairy sheep mastitis
Addis, M. F., Tedde, V., Dore, S., Pisanu, S., Puggioni, G., Roggio, A. M., Pagnozzi, D., Lollai, S. A., Cannas, E. A., & Uzzau, S. (2016) · Journal of Dairy Science · doi:10.3168/jds.2015-10293 · Cited by 45
“laboratory or field immunoassay tests (Baker, 2015; Bradbury and Plückthun, 2015).”
BackgroundIrreproducibility of published bioscience research: Diagnosis, pathogenesis and therapy
Flier, J. S. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.11.006 · Cited by 49
“Antibodies that claim to have specificity for antigens, but lack such, commonly continue to be employed [28] even after the demonstrated lack of specificity has been published.”
BackgroundKosmidou, C., Efstathiou, N. E., Hoang, M. V., Notomi, S., Konstantinou, E. K., Hirano, M., Takahashi, K., Maidana, D. E., Tsoka, P., Young, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-17634-1 · Cited by 47
Unfolding of IgG domains detected by non-reducing SDS-PAGE
Kirley, T. L., & Norman, A. B. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.100 · Cited by 45
“However, it has been reported that a large percentage of commercially available antibodies for basic research are unable to accurately and selectively recognize their intended targets [1,2], and there are substantial ongoing efforts to systematically validate antibodies for their intended usages and targets.”
Bukari, B. A., Samarasinghe, R. M., Noibanchong, J., & Shigdar, S. L. (2020) · Biomedicines · doi:10.3390/biomedicines8050120 · Cited by 50
Strong Inference in Mathematical Modeling: A Method for Robust Science in the Twenty-First Century
Ganusov, V. V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01131 · Cited by 49
“…2015), improved trainings (Moher and Altman, 2015), performing blind analyses of the data (MacCoun and Perlmutter, 2015), the need for independent analyses of the same data/models by different teams prior to publication (Silberzahn and Uhlmann, 2015), and standardization of tools (Baker, 2015).”
BackgroundGuan, P., Guo, Z., Xu, S., Hai-feng, L., Wang, L., Gu, Z., & Liu, Z. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202301202 · Cited by 46
Parkinson disease and progressive supranuclear palsy: protein expression in skin
Rodríguez‐Leyva, I., Chi-Ahumada, É., Carrizales-Rodríguez, J., Rodríguez‐Violante, M., Velázquez‐Osuna, S., Medina‐Mier, V., Gallegos, M. G. M., Zarazúa, S., Enríquez‐Macías, L., Castro‐Zavala, A., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.285 · Cited by 45
“Finally, concerning the dispersion of the obtained data, since our study was made with the clinical, not histopathological diagnosis of PD and PSP the outliers are possible, a factible explanation could be the variation among different batches of commercial antibodies, a common problem that is increasingly gaining att…”
ResultHewitt, S. H., Ali, R., Mailhot, R., Antonen, C. R., Dodson, C. A., & Butler, S. J. (2019) · Chemical Science · doi:10.1039/c9sc01552c · Cited by 44
Aptamer-protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells
Xu, X. S., Li, L., Li, X., Tao, D., Zhang, P., & Gong, J. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119963 · Cited by 43
Preparation of a Chicken scFv to Analyze Gentamicin Residue in Animal Derived Food Products
Li, C., He, J., Ren, H., Zhang, X., Du, E., & Li, X. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b00426 · Cited by 44
Nomenclature of CD molecules from the Tenth Human Leucocyte Differentiation Antigen Workshop
Clark, G. J., Stockinger, H. S. J., BALDERAS, R. S., van Zelm, M. C., Zola, H., Hart, D. N. J., & Engel, P. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2015.38 · Cited by 41
Prasad, S., Lassetter, B., Welker, K. M., & Mehta, P. H. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104373 · Cited by 41
“These concerns about reproducibility echo concerns raised by other scientists, who have argued that batch-to-batch variability in antibodies may be creating a “reproducibility crisis” across the biological sciences (Baker, 2015).”
BackgroundInfluentialSensing serotonin secreted from human serotonergic neurons using aptamer-modified nanopipettes
Nakatsuka, N., Heard, K. J., Faillétaz, A., Momotenko, D., Vörös, J., Gage, F. H., & Vadodaria, K. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01066-5 · Cited by 52
Comparison of human Nrf2 antibodies: A tale of two proteins
Kemmerer, Z. A., Ader, N. R., Mulroy, S. S., & Eggler, A. L. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.07.004 · Cited by 41
“) These practices reflect a recent broader call in the life sciences to improve reproducibility of results by validating antibodies in each assay of interest and by reporting antibody usage details (Baker, 2015).”
BackgroundGuidelines for manuscript submission in the peer-reviewed pharmacological literature
Mullane, K., Enna, S. J., Piette, J. G., & Williams, M. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.023 · Cited by 44
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.